Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?

The generation of induced pluripotent stem (iPS) cells from somatic cells by the ectopic expression of defined transcription factors has provided the regenerative medicine field with a new tool for cell replacement strategies. The advantages that these pluripotent cells can offer in comparison to other sources of stem cells include the generation of patient-derived cells and the lack of embryonic tissue while maintaining a versatile differentiation potential. The promise of iPS cell derivatives for therapeutic applications is encouraging albeit very early in development, with the first clinical study currently ongoing in Japan. Many challenges are yet to be circumvented before this technology can be clinically translated widely though. The delivery and expression of the reprogramming factors, the genomic instability, epigenetic memory and impact of cell propagation in culture are only some of the concerns. This article aims to critically discuss the potential of iPS cells as a new source of cell therapeutics.

[1]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[2]  K. Reymann,et al.  Human Induced Pluripotent Stem Cells Improve Stroke Outcome and Reduce Secondary Degeneration in the Recipient Brain , 2012, Cell transplantation.

[3]  Sophie C Cox,et al.  Biomaterial scaffolds for tissue engineering. , 2013, Frontiers in bioscience.

[4]  S. Charache.  Treatment of sickle cell anemia. , 1981, Annual review of medicine.

[5]  Robert Lanza,et al.  Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. , 2009, Cell stem cell.

[6]  F. Müller,et al.  A call to standardize teratoma assays used to define human pluripotent cell lines. , 2010, Cell stem cell.

[7]  J. Yates,et al.  Recapitulation of premature aging with iPSCs from Hutchinson-Gilford progeria syndrome , 2011, Nature.

[8]  T. Lufkin,et al.  Emerging Stem Cell Therapies: Treatment, Safety, and Biology , 2012, Stem cells international.

[9]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[10]  G. Welstead,et al.  Generation of induced pluripotent stem cells by reprogramming mouse embryonic fibroblasts with a four transcription factor, doxycycline inducible lentiviral transduction system. , 2009, Journal of visualized experiments : JoVE.

[11]  D. Prockop,et al.  Concise Review: Mesenchymal Stem/Multipotent Stromal Cells: The State of Transdifferentiation and Modes of Tissue Repair—Current Views , 2007, Stem cells.

[12]  K. Plath,et al.  Generation of human induced pluripotent stem cells from dermal fibroblasts , 2008, Proceedings of the National Academy of Sciences.

[13]  M. Serrano,et al.  Reprogramming in vivo produces teratomas and iPS cells with totipotency features , 2013, Nature.

[14]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[15]  J. Bradley,et al.  Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. , 2012, Cell stem cell.

[16]  R. Jaenisch,et al.  Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[17]  Kostas Kostarelos,et al.  In Vivo Cell Reprogramming towards Pluripotency by Virus-Free Overexpression of Defined Factors , 2013, PloS one.

[18]  A. Chandra,et al.  Transplantation of human neuro-epithelial-like stem cells derived from induced pluripotent stem cells improves neurological function in rats with experimental intracerebral hemorrhage , 2013, Neuroscience Letters.

[19]  G. Daley,et al.  The promise of induced pluripotent stem cells in research and therapy , 2012, Nature.

[20]  Timothy J. Nelson,et al.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. , 2009, Circulation.

[21]  G. Daley,et al.  Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients , 2009, Nature.

[22]  C. Siu,et al.  Functional Mesenchymal Stem Cells Derived From Human Induced Pluripotent Stem Cells Attenuate Limb Ischemia in Mice , 2010, Circulation.

[23]  Kathrin Plath,et al.  Progress in understanding reprogramming to the induced pluripotent state , 2011, Nature Reviews Genetics.

[24]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[25]  J. Adjaye,et al.  Current Methods for Inducing Pluripotency in Somatic Cells , 2013, Advanced materials.

[26]  Shinya Yamanaka,et al.  Induced pluripotent stem cells in medicine and biology , 2013, Development.

[27]  M. Hartman,et al.  Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair. , 2016, Advanced drug delivery reviews.

[28]  Zohar Mukamel,et al.  Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.

[29]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[30]  Kristopher L. Nazor,et al.  Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells , 2012, Nature.

[31]  S. Tsang,et al.  3 1 2 | L I E T a L . | M O L M E D 1 8 : 1 3 1 2 -1 3 1 9 , 2 0 1 2 , 2022 .

[32]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[33]  A. Connolly,et al.  In vivo imaging of embryonic stem cells reveals patterns of survival and immune rejection following transplantation. , 2008, Stem cells and development.

[34]  A. Swaroop,et al.  Developing Rods Transplanted into the Degenerating Retina of Crx‐Knockout Mice Exhibit Neural Activity Similar to Native Photoreceptors , 2013, Stem cells.

[35]  K. Plath,et al.  Epigenetics of Reprogramming to Induced Pluripotency , 2013, Cell.

[36]  A. Nagy,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Concise Review : Embryonic Stem Cells Versus Induced Pluripotent Stem Cells : The Game Is On , 2011 .

[37]  Takashi Aoi,et al.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.

[38]  K. Tokunaga,et al.  Human Leukocyte Antigen Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy , 2007, Stem cells.

[39]  Emanuela Monni,et al.  Human‐Induced Pluripotent Stem Cells form Functional Neurons and Improve Recovery After Grafting in Stroke‐Damaged Brain , 2012, Stem cells.

[40]  M. Hasegawa,et al.  Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome , 2009, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[41]  J. Polak,et al.  Stem cells in regenerative medicine: introduction. , 2011, British medical bulletin.

[42]  H. Hioki,et al.  Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells , 2012, Science Translational Medicine.

[43]  Teng Hong Tan,et al.  Modeling type 3 long QT syndrome with cardiomyocytes derived from patient-specific induced pluripotent stem cells. , 2013, International journal of cardiology.

[44]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[45]  Sandy L. Klemm,et al.  Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase , 2012, Cell.

[46]  S. Boesch,et al.  Induced pluripotent stem cells from friedreich ataxia patients fail to upregulate frataxin during in vitro differentiation to peripheral sensory neurons. , 2013, Stem cells and development.

[47]  C. Álvarez,et al.  Defining stem cell types: understanding the therapeutic potential of ESCs, ASCs, and iPS cells. , 2012, Journal of molecular endocrinology.

[48]  N. Rodrigues,et al.  Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. , 2013, Cell stem cell.

[49]  M. Stojkovic,et al.  Human stem cell research and regenerative medicine--present and future. , 2011, British medical bulletin.

[50]  S. Ramaswamy,et al.  A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells , 2012, Cell.

[51]  J. Bilić,et al.  Concise Review: Induced Pluripotent Stem Cells Versus Embryonic Stem Cells: Close Enough or Yet Too Far Apart? , 2012, Stem cells.

[52]  M. Peschanski,et al.  Human pluripotent stem cells for disease modelling and drug screening. , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.

[53]  Jinqiu Zhang,et al.  A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects. , 2011, Cell stem cell.

[54]  Suk-Ho Lee,et al.  Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. , 2011, The Journal of clinical investigation.

[55]  F. Alt,et al.  Excision of Reprogramming Transgenes Improves the Differentiation Potential of iPS Cells Generated with a Single Excisable Vector , 2009, Stem cells.

[56]  Riitta Lahesmaa,et al.  Copy number variation and selection during reprogramming to pluripotency , 2011, Nature.

[57]  Mudit Gupta,et al.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. , 2011, Cell stem cell.

[58]  E. Stone,et al.  Use of a Synthetic Xeno‐Free Culture Substrate for Induced Pluripotent Stem Cell Induction and Retinal Differentiation , 2013, Stem cells translational medicine.

[59]  R. Jaenisch,et al.  Reprogramming of human peripheral blood cells to induced pluripotent stem cells. , 2010, Cell stem cell.

[60]  Xiao-Bing Zhang,et al.  Cellular Reprogramming of Human Peripheral Blood Cells , 2013, Genom. Proteom. Bioinform..

[61]  L. Studer,et al.  Identification of Compounds that Rescue IKBKAP Expression in Familial Dysautonomia-iPS Cells , 2012, Nature Biotechnology.

[62]  Jennifer M. Bolin,et al.  Chemically defined conditions for human iPS cell derivation and culture , 2011, Nature Methods.

[63]  S. Yamanaka,et al.  An Efficient Nonviral Method to Generate Integration‐Free Human‐Induced Pluripotent Stem Cells from Cord Blood and Peripheral Blood Cells , 2013, Stem cells.

[64]  K. Hochedlinger,et al.  EMBRYONIC STEM CELLS / INDUCED PLURIPOTENT STEM CELLS Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette , 2009 .

[65]  Shinya Yamanaka,et al.  A Fresh Look at iPS Cells , 2009, Cell.

[66]  I Wilmut,et al.  Induced pluripotent stem cells: epigenetic memories and practical implications. , 2010, Molecular human reproduction.

[67]  H. Onoe,et al.  Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model of Parkinson's disease. , 2011, Journal of Parkinson's disease.

[68]  M. Pekkanen-Mattila,et al.  A Defined and Xeno-Free Culture Method Enabling the Establishment of Clinical-Grade Human Embryonic, Induced Pluripotent and Adipose Stem Cells , 2010, PloS one.

[69]  A. Abbott.  Leaked files slam stem-cell therapy , 2014, Nature.

[70]  I. Sancho-Martinez,et al.  Reprogramming of human fibroblasts to pluripotency with lineage specifiers. , 2013, Cell stem cell.

[71]  Fred H. Gage,et al.  Induced pluripotent stem cells: the new patient? , 2012, Nature Reviews Molecular Cell Biology.

[72]  S. Yamanaka,et al.  Generation of retinal cells from mouse and human induced pluripotent stem cells , 2009, Neuroscience Letters.

[73]  George Q. Daley,et al.  Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.

[74]  Paul H Lerou,et al.  Generation of human-induced pluripotent stem cells , 2008, Nature Protocols.

[75]  D. Cyranoski.  Stem cells cruise to clinic , 2013, Nature.

[76]  In-Hyun Park.  DYS-HAC-iPS cells: the combination of gene and cell therapy to treat duchenne muscular dystrophy. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[77]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[78]  Shinya Yamanaka,et al.  Generation of Mouse Induced Pluripotent Stem Cells Without Viral Vectors , 2008, Science.

[79]  Tory M. Schaaf,et al.  An ex vivo Gene Therapy Approach to Treat Muscular Dystrophy Using inducible Pluripotent Stem Cells , 2013, Nature Communications.

[80]  S. Ricardo,et al.  Human kidney cell reprogramming: applications for disease modeling and personalized medicine. , 2013, Journal of the American Society of Nephrology : JASN.

[81]  Marius Wernig,et al.  Treatment of Sickle Cell Anemia Mouse Model with iPS Cells Generated from Autologous Skin , 2007, Science.

[82]  H. Okano,et al.  Grafted human-induced pluripotent stem-cell–derived neurospheres promote motor functional recovery after spinal cord injury in mice , 2011, Proceedings of the National Academy of Sciences.

[83]  Yong Soon Chun,et al.  Applications of Patient-Specific Induced Pluripotent Stem Cells; Focused on Disease Modeling, Drug Screening and Therapeutic Potentials for Liver Disease , 2010, International journal of biological sciences.

[84]  K. Tashiro.  Optimization of adenovirus vectors for transduction in embryonic stem cells and induced pluripotent stem cells. , 2011, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[85]  D. Cyranoski.  Stem-cell pioneer banks on future therapies , 2012, Nature.

[86]  Daniele Linaro,et al.  Pyramidal Neurons Derived from Human Pluripotent Stem Cells Integrate Efficiently into Mouse Brain Circuits In Vivo , 2013, Neuron.

[87]  R. Jaenisch,et al.  Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats , 2010, Proceedings of the National Academy of Sciences.

[88]  H. Baharvand,et al.  Differentiation and Transplantation of Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells , 2011, Stem Cell Reviews and Reports.

[89]  J. Gottesfeld,et al.  Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells. , 2013, Human molecular genetics.

[90]  K. Eggan,et al.  Modeling human disease with pluripotent stem cells: from genome association to function. , 2013, Cell stem cell.

[91]  Chulhee Choi,et al.  Endothelial progenitor cells from human dental pulp-derived iPS cells as a therapeutic target for ischemic vascular diseases. , 2013, Biomaterials.

[92]  Kostas Kostarelos,et al.  In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors , 2013, Journal of visualized experiments : JoVE.

[93]  P. Song,et al.  Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies. , 2013, Bioscience trends.

[94]  R. Stewart,et al.  Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.

[95]  S. Yamanaka,et al.  To be immunogenic, or not to be: that's the iPSC question. , 2013, Cell stem cell.

[96]  J. Kuo,et al.  Introduction to induced pluripotent stem cells: advancing the potential for personalized medicine. , 2011, World neurosurgery.

[97]  W. Lowry,et al.  Roadblocks en route to the clinical application of induced pluripotent stem cells , 2010, Journal of Cell Science.

[98]  L. Fortier.  Stem cells: classifications, controversies, and clinical applications. , 2005, Veterinary surgery : VS.

[99]  Mo Li,et al.  Cell fate conversion by mRNA , 2011, Stem Cell Research & Therapy.

[100]  Yang Xu,et al.  Immunogenicity of induced pluripotent stem cells , 2011, Nature.

[101]  Shinya Yamanaka,et al.  Generation of mouse-induced pluripotent stem cells with plasmid vectors , 2010, Nature Protocols.

[102]  Kathryn J Wood,et al.  Embryonic Stem Cells and Their Differentiated Derivatives Have a Fragile Immune Privilege but Still Represent Novel Targets of Immune Attack , 2008, Stem cells.

[103]  K. Abe,et al.  Tridermal Tumorigenesis of Induced Pluripotent Stem Cells Transplanted in Ischemic Brain , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[104]  L. Marchionni,et al.  In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins , 2011, Science Translational Medicine.

[105]  T. Ichisaka,et al.  Generation of germline-competent induced pluripotent stem cells , 2007, Nature.

[106]  D. Gamm,et al.  Modeling retinal degenerative diseases with human iPS-derived cells: current status and future implications , 2013, Expert review of ophthalmology.

[107]  Stéphanie Boué,et al.  Methods for making induced pluripotent stem cells: reprogramming à la carte , 2011, Nature Reviews Genetics.

[108]  G. Daley,et al.  Generation of induced pluripotent stem cells from human blood. , 2009, Blood.

[109]  M. Kaufman,et al.  Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.

[110]  Su-Chun Zhang,et al.  Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[111]  Yasuko Matsumura,et al.  A more efficient method to generate integration-free human iPS cells , 2011, Nature Methods.

[112]  S. Yamanaka,et al.  Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation , 2014, Cell.

[113]  K. Isobe,et al.  Therapeutic angiogenesis by transplantation of induced pluripotent stem cell-derived Flk-1 positive cells , 2010, BMC Cell Biology.

[114]  A. Abbott.  Cell rewind wins medicine Nobel , 2012, Nature.

[115]  Hideyuki Okano,et al.  Variation in the safety of induced pluripotent stem cell lines , 2009, Nature Biotechnology.

[116]  D. Cyranoski.  iPS cells in humans , 2013, Nature Biotechnology.

[117]  P. Mali,et al.  Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined Conditions , 2010, Stem cells.

[118]  R. Stewart,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[119]  K. Wood,et al.  Immunogenicity of embryonic stem cell-derived progenitors after transplantation , 2011, Current opinion in organ transplantation.